Profile data is unavailable for this security.
About the company
Telo Genomics Corp. is a Canada-based biotech company. The Company is focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display genomic instability. Its lead product, TeloView SMM, is a high-complexity molecular assay available for clinical use to provide information to physicians treating patients with Smoldering Multiple Myeloma. Through proprietary telomere-based analysis, TeloView SMM selects high-risk SMM patients who are likely to benefit from earlier treatment intervention while identifying the larger subset of low-risk SMM patients who have a more stable form of the disease and do not require immediate treatment. The TeloView SMM assay has a potential total addressable market of over 500,000 tests per year.
- Revenue in CAD (TTM)0.00
- Net income in CAD-3.07m
- Incorporated2011
- Employees--
- LocationTelo Genomics CorpMars Centre, 101 College St Suite 200TORONTO M5G 1L7CanadaCAN
- Phone+1 (416) 673-8487
- Fax+1 (204) 582-0922
- Websitehttps://www.telodx.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delivra Health Brands Inc | 11.39m | -1.11m | 10.94m | -- | -- | 2.90 | 52.10 | 0.9606 | -0.0044 | -0.0044 | 0.0423 | 0.012 | 1.05 | 2.17 | 5.95 | -- | -10.26 | -45.81 | -20.21 | -58.34 | 56.21 | 37.95 | -9.78 | -289.55 | 1.42 | -0.3789 | 0.346 | -- | 20.30 | 68.26 | 97.37 | -- | -56.72 | -- |
| Valeo Pharma Inc | 54.29m | -28.43m | 11.35m | 100.00 | -- | -- | -- | 0.209 | -0.3255 | -0.3255 | 0.6249 | -0.4765 | 1.23 | 3.53 | 12.39 | 434,296.00 | -64.52 | -64.35 | -215.78 | -113.22 | 21.38 | 23.88 | -52.37 | -69.71 | 0.2974 | -1.33 | 3.51 | -- | 94.31 | 65.20 | -8.01 | -- | 76.61 | -- |
| Willow Biosciences Inc | 1.17m | -13.03m | 11.43m | 19.00 | -- | 3.26 | -- | 9.75 | -0.105 | -0.105 | 0.0094 | 0.0276 | 0.0944 | -- | 5.23 | 61,684.21 | -104.98 | -- | -122.40 | -- | -- | -- | -1,111.69 | -- | 2.18 | -- | 0.3856 | -- | 42.75 | -- | 12.05 | -- | -- | -- |
| Telo Genomics Corp | 0.00 | -3.07m | 12.12m | -- | -- | 10.06 | -- | -- | -0.0468 | -0.0468 | 0.00 | 0.0169 | 0.00 | -- | -- | -- | -195.00 | -85.03 | -222.53 | -113.86 | -- | -- | -- | -- | -- | -- | 0.0263 | -- | -- | -- | -33.66 | -- | 24.41 | -- |
| Indiva Ltd | 36.01m | -6.94m | 12.71m | 142.00 | -- | 32.62 | -- | 0.3529 | -0.0471 | -0.0471 | 0.2307 | 0.002 | 0.9317 | 6.59 | 9.24 | -- | -17.96 | -32.56 | -29.41 | -48.73 | 25.29 | 16.88 | -19.27 | -74.28 | 0.6058 | -1.01 | 0.9833 | -- | 5.95 | -- | 27.16 | -- | -18.11 | -- |
| AEterna Zentaris Inc. | 6.15m | -22.63m | 12.88m | 21.00 | -- | 0.5179 | -- | 2.10 | -4.66 | -4.66 | 1.27 | 5.12 | 0.0967 | 1.51 | 19.14 | -- | -35.58 | -26.24 | -40.64 | -30.34 | 95.06 | 83.68 | -368.01 | -300.31 | 8.00 | -- | 0.0151 | -- | -20.25 | -30.06 | 27.17 | -- | 16.12 | -- |
| Avricore Health Inc | 3.11m | -1.01m | 13.48m | -- | -- | 7.45 | -- | 4.34 | -0.0101 | -0.0101 | 0.0313 | 0.0181 | 1.36 | -- | 7.56 | -- | -43.90 | -132.19 | -56.53 | -219.49 | 28.02 | 26.28 | -32.36 | -460.06 | -- | -59.16 | 0.0217 | -- | 1,339.92 | 26.88 | 52.10 | -- | 216.40 | -- |
